Bellerophon Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bellerophon Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2022.
  • Bellerophon Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $56.6M, a 8.53% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $56.6M +$4.45M +8.53% Dec 31, 2022 10-K 2023-03-31
Q4 2021 $52.2M -$13.3M -20.3% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $65.5M +$5.91M +9.92% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $59.5M +$4.56M +8.3% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $55M +$2.93M +5.62% Dec 31, 2018 10-K 2020-04-06
Q4 2017 $52.1M +$2.46M +4.96% Dec 31, 2017 10-K 2019-03-14
Q4 2016 $49.6M +$9.27M +23% Dec 31, 2016 10-K 2018-03-15
Q4 2015 $40.3M Dec 31, 2015 10-K 2017-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.